CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BIIB

Omaveloxolone

Phase 3
Biogen Inc. (BIIB)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
BIIBPhase 3

Omaveloxolone Phase 3 Est. Readout (BRAVE)

Omaveloxolone
Q4 2027~Q
CT.gov
00%
Competitive Landscape

1 competitor in Friedreich Ataxia

View Full Landscape
Drug Information

Target Indication

Friedreich Ataxia

Clinical Trial

NCT06953583

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA2/9/2024

Skyclarys

The treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older.

Orphan
View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.